Dawn Sauro supports the overall clinical development organization at Clinipace as the chief development officer. Sauro has over 20 years of industry experience and will support the growth and drive strategy for the organization, leveraging her experience in delivering registration programs across multiple therapeutic areas.
Prior to joining Clinipace, Sauro was president of Sarah Cannon Development Innovations, the full-service, oncology-focused CRO at Sarah Cannon. In this role, she leveraged her cross-functional operational experience and strategic initiatives to yield significant increases in revenue and margin. Her prior roles include senior vice president at inVentiv Health (now Syneos) where she led the hematology/oncology and general medicines divisions. She also served as vice president, general partner, at PRA Health Sciences and director of clinical operations at PPD.